Literature DB >> 26626081

Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.

Anne B Rocher1, Paolo Gubellini2, Nicolas Merienne3, Lydie Boussicault3, Fanny Petit3, Pauline Gipchtein3, Caroline Jan3, Philippe Hantraye3, Emmanuel Brouillet3, Gilles Bonvento4.   

Abstract

Huntington's disease (HD) is an autosomal dominant disease that develops in midlife (~ 40 years-old at onset) and then progresses slowly. It is still unclear how striatal medium spiny neurons (MSNs), the most vulnerable neurons in HD, maintain their function for decades despite the chronic expression of mutant huntingtin (mHTT). In this study, we used aged BACHD mice, a HD model expressing the full-length human mHTT gene, to investigate the molecular, morphological and functional properties of striatal MSNs. We report that the density of dendritic spines in MSNs is substantially lower in aged BACHD mice than in wild-type (WT) mice, in the absence of major dendritic changes and neuronal loss. This spine loss is accompanied by changes in transcription, resulting in a low expression of the striatum-specific G protein-coupled receptor 88 (Gpr88) as well as a reorganization of the composition of AMPAR subunits (high Gria1/Gria2 mRNA ratio). We also detected functional changes in BACHD MSNs. Notably, BACHD MSNs were hyperexcitable and the amplitude of AMPAR-mediated synaptic currents was higher than in WT MSNs. Altogether, these data show that both the intrinsic properties and the strength of the remaining synapses are modified in MSNs with low dendritic spine density in aged BACHD mice. These homeostatic mechanisms may compensate for the substantial loss of synaptic inputs and thus alleviate the deleterious effects of mHTT expression on the activity of MSNs and also possibly on the motor phenotype in aged BACHD.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMPAR; Dendritic spine; Homeostatic scaling; Huntington's disease; Medium spiny neuron; Whole-cell patch-clamp

Mesh:

Substances:

Year:  2015        PMID: 26626081     DOI: 10.1016/j.nbd.2015.10.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  8 in total

Review 1.  Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.

Authors:  Na Ye; Bang Li; Qi Mao; Eric A Wold; Sheng Tian; John A Allen; Jia Zhou
Journal:  ACS Chem Neurosci       Date:  2018-12-20       Impact factor: 4.418

2.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

Review 3.  Calcium Permeable-AMPA Receptors and Excitotoxicity in Neurological Disorders.

Authors:  Changyong Guo; Yao-Ying Ma
Journal:  Front Neural Circuits       Date:  2021-08-17       Impact factor: 3.342

Review 4.  Neuronal Plasticity: Neuronal Organization is Associated with Neurological Disorders.

Authors:  Yogesh Kumar Dhuriya; Divakar Sharma
Journal:  J Mol Neurosci       Date:  2020-06-06       Impact factor: 3.444

5.  A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice.

Authors:  Danielle A Simmons; Nadia P Belichenko; Ellen C Ford; Sarah Semaan; Marie Monbureau; Sruti Aiyaswamy; Cameron M Holman; Christina Condon; Mehrdad Shamloo; Stephen M Massa; Frank M Longo
Journal:  Hum Mol Genet       Date:  2016-11-15       Impact factor: 6.150

6.  Exosomes and Homeostatic Synaptic Plasticity Are Linked to Each other and to Huntington's, Parkinson's, and Other Neurodegenerative Diseases by Database-Enabled Analyses of Comprehensively Curated Datasets.

Authors:  James K T Wang; Peter Langfelder; Steve Horvath; Michael J Palazzolo
Journal:  Front Neurosci       Date:  2017-03-31       Impact factor: 4.677

7.  Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease.

Authors:  Mandi E Schmidt; Caodu Buren; James P Mackay; Daphne Cheung; Louisa Dal Cengio; Lynn A Raymond; Michael R Hayden
Journal:  BMC Biol       Date:  2018-06-27       Impact factor: 7.431

8.  Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+/- mouse model of Huntington's Disease.

Authors:  Joseph W Goodliffe; Hanbing Song; Anastasia Rubakovic; Wayne Chang; Maria Medalla; Christina M Weaver; Jennifer I Luebke
Journal:  PLoS One       Date:  2018-08-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.